• ქართული
  • English
  • AbbVie beats estimates as Humira sales fall less than feared

    Drugmaker AbbVie Inc’s quarterly revenue beat Wall Street estimates on Thursday, as the decline in sales of its blockbuster rheumatoid arthritis drug Humira was not as steep as expected.

    Market Quotes by TradingView